TrialActa haematologica2021

Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of Panobinostat in Combination with Bortezomib and Dexamethasone in Japanese Patients with Relapsed or Relapsed-and-Refractory Multiple Myeloma.

Kenshi Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.